Carole Ann Cartier

Carole Ann Cartier has extensive work experience in the field of regulatory affairs. Carole Ann currently holds the role of Executive Director, Regulatory Strategy at Framework Solutions, LLC since June 2023. Prior to that, they worked as a Principal Consultant in Regulatory Affairs at Opus Regulatory, Inc. from September 2018 to April 2023. Before joining Opus Regulatory, Inc., Cartier served as the Senior Director of Regulatory Affairs at LYSOGENE from January 2018 to September 2018. Carole Ann also worked as the Director of Regulatory Affairs at Seres Therapeutics from September 2015 to January 2018. Carole Ann'sprevious roles include Associate Director of Regulatory Affairs at Syndax Pharmaceuticals, Inc. from January 2014 to September 2015, Director of Regulatory Affairs at Genzyme from October 2012 to August 2013, and Director of Regulatory Affairs at Amgen from November 2010 to January 2012. Prior to that, Cartier worked at Millennium - The Takeda Oncology Company from November 2006 to October 2010, where they held the position of Scientific & Competitive Intelligence / Regulatory Affairs - Regulatory Strategy & Intelligence. Carole Ann began their career as an Associate Director of Regulatory Affairs at Idenix Pharmaceuticals from July 2005 to November 2006.

Carole Ann Cartier has a strong educational background in the field of regulatory affairs and pharmaceutical/chemical studies. Carole Ann holds a Master's degree in Regulatory Affairs for Drugs, Biologics, and Medical Devices from Northeastern University. In addition, they have completed an MBA in Pharmaceutical/Chemical Studies from Fairleigh Dickinson University. Carole Ann Cartier also possesses a Bachelor's degree in Biology/Chemistry from Saint Elizabeth University. Furthermore, they have obtained a certification in Regulatory Affairs from the Regulatory Affairs Professionals Society (RAPS).